Ixekizumab is a humanized monoclonal antibody for the treatment of autoimmune diseases. More specifically it is being tested for the use in psoriasis. A Phase II clinical trial including patients […]
List of articles in "Drug" category - Page 63
Intetumumab
Intetumumab is a human monoclonal antibody used in the treatment of solid tumors.Intetumumab was developed by Centocor Inc.
Gevokizumab
Gevokizumab is a potent monoclonal antibody developed by XOMA Corporation with unique allosteric modulating properties and the potential to treat patients with a wide variety of inflammatory and other diseases. […]
Icrucumab
Icrucumab is a human monoclonal antibody designed for the treatment of solid tumors.Icrucumab was developed by ImClone Systems Inc.
Ganitumab
Ganitumab is a human monoclonal antibody against type 1 insulin-like growth factor receptor (IGF1R) designed for the treatment of cancers.Ganitumab was developed by Amgen. A phase III clinical trial (for […]
Fulranumab
Fulranumab is a human monoclonal antibody designed for the treatment of pain.Fulranumab was developed by Johnson & Johnson.
Flanvotumab
Flanvotumab is a human monoclonal antibody designed for the treatment of melanoma.Flanvotumab was developed by ImClone Systems.
Ficlatuzumab
Ficlatuzumab is a humanized monoclonal antibody designed for the treatment of cancers.Ficlatuzumab was developed by AVEO Pharmaceuticals. In May 2012 AVEO released results of a Phase II clinical trial comparing […]
Etrolizumab
Etrolizumab is a humanized monoclonal antibody designed for the treatment of inflammatory bowel disease.Etrolizumab was developed by Genentech.
Ensituximab
Ensituximab is a chimeric monoclonal antibody used in the treatment of cancers.Ensituximab was developed by Neogenix Oncology Inc.